MROH7: A Promising Drug Target and Biomarker (G374977)

Target Name: MROH7

NCBI ID: G374977

MROH7

MROH7: A Promising Drug Target and Biomarker

MROH7 (DKFZp781B0622) is a drug target and a potential biomarker for the treatment of various diseases, including cancer. Its unique structure and function make it an attractive target for drug development.

MROH7 is a protein that is expressed in various tissues and organs, including the brain, muscle, heart, and blood vessels. It is a member of the superfamily of F-actinin-like proteins, which are involved in many cellular processes. MROH7 is unique in that it is a type of actinin-like protein that is expressed in the brain, and it has been shown to play a role in the regulation of neural stem cell proliferation and differentiation.

One of the most promising aspects of MROH7 is its potential as a drug target. The actinin-like proteins that MROH7 is a member of have been shown to play a role in many diseases, including cancer. MROH7 is thought to be involved in the regulation of cellular processes that are important for cancer development, such as cell division, angiogenesis, and inflammation.

In addition to its potential as a drug target, MROH7 has also been shown to be a potential biomarker for the treatment of various diseases. Its expression has been shown to be associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes MROH7 an attractive candidate for use as a diagnostic or therapeutic target.

One of the challenges in studying MROH7 is its complex structure. Despite its unique function, MROH7 is a protein that is difficult to study. Its high level of expression and its complex structure make it difficult to detect and manipulate the protein in a controlled manner. However, researchers are constantly working to develop new techniques for studying MROH7, and these efforts are likely to continue as the field of pharmacology continues to evolve.

In conclusion, MROH7 is a drug target and a potential biomarker for the treatment of various diseases. Its unique structure and function make it an attractive target for drug development, and its potential as a diagnostic or therapeutic target continues to grow. Researchers are constantly working to study MROH7, and these efforts are likely to continue as the field of pharmacology continues to evolve.

Protein Name: Maestro Heat Like Repeat Family Member 7

The "MROH7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MROH7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets